Clinical Trials Directory

Trials / Sponsors / Janssen-Cilag International NV

Janssen-Cilag International NV

Industry · 67 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings
Schizophrenia
Phase 42021-07-22
CompletedA Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With
Depressive Disorder, Major
Phase 32020-08-21
WithdrawnA Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus
Depressive Disorder, Treatment-Resistant
Phase 32019-12-01
TerminatedA Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment
Kidney Failure, Chronic
Phase 12019-07-02
CompletedA Study of Orally Administered Pimodivir in Adult Participants With Hepatic Impairment
Hepatic Impairment
Phase 12019-05-28
CompletedA Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Pla
Psoriasis
Phase 32019-02-08
CompletedA Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organi
Healthy
Phase 12018-12-06
CompletedA Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching
Schizophrenia
2018-11-21
CompletedA Study to Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human
Respiratory Tract Infections
2018-06-27
CompletedA Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 S
Healthy
Phase 12018-06-08
CompletedA Positron Emission Tomography (PET) Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-
Healthy
Phase 12018-03-15
Active Not RecruitingA Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate
Psoriasis
2017-10-25
CompletedA Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of
Healthy
Phase 12017-08-14
CompletedA Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55308942 in Healthy Male and Fema
Healthy
Phase 12017-05-03
CompletedA Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacoki
Healthy
Phase 12017-04-05
CompletedA Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor Positron
Healthy
Phase 12017-03-24
CompletedA Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Co
Healthy
Phase 12017-02-14
CompletedA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274
Healthy
Phase 12016-08-13
CompletedSafety, Tolerability, Pharmacokinetic and Absolute Bioavailability Study of JNJ-63623872 Administered as an In
Healthy
Phase 12016-08-08
CompletedStudy to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-61393215 in Healthy
Healthy
Phase 12016-07-07
CompletedAn Observational Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea in Type 2 Diabetes Patients
Diabetes Mellitus, Type 2
2016-04-01
TerminatedA Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting
Gastroenteritis
Phase 32015-12-07
CompletedPilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Sin
Healthy
Phase 12015-11-01
CompletedA Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Hea
Healthy
Phase 12015-08-01
CompletedA Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder
Major Depressive Disorder
Phase 12015-06-11
CompletedA Study to Investigate Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of JNJ-5417
Healthy
Phase 12015-06-01
CompletedA Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatiti
Hepatitis C, Chronic
Phase 22015-01-01
CompletedAn Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir
Hepatitis C
Phase 22014-12-01
CompletedA Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42847922 in Healthy
Healthy
Phase 12014-05-01
CompletedA Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RP
Human Immunodeficiency Virus-type 1 Infection
Phase 32013-10-02
CompletedA Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
Hepatitis C, Chronic, Infection
Phase 32013-09-01
CompletedA Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers
Healthy
Phase 12013-07-01
CompletedA Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting
Schizophrenia
2013-05-01
CompletedStudy to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib
Multiple Myeloma
Phase 32013-04-01
CompletedA Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bu
Hallux Valgus
Phase 32013-01-01
CompletedEffects of Canagliflozin on C-peptide Clearance in Healthy Volunteers
Healthy
Phase 12012-09-01
CompletedA Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Par
Healthy
Phase 12012-08-01
CompletedTelaprevir Open-Label Study in Co-Infected Patients
Hepatitis C, Chronic
Phase 32012-06-01
CompletedAn Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) an
Chronic Hepatitis C
Phase 32012-04-01
CompletedA Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy
Human Immunodeficiency Virus (HIV) Infections, Acquired Immunodeficiency Syndrome (AIDS) Virus
Phase 32012-03-15
CompletedAn Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Trans
Chronic Hepatitis C Virus (HCV) Infection
Phase 32012-02-01
CompletedOpen-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Ge
Genotype 1 Chronic Hepatitis C
Phase 32012-01-01
CompletedAn Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes
Myelodysplastic Syndromes
Phase 32011-10-01
CompletedA Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in
Healthy Volunteers, Pharmacokinetics
Phase 12011-08-01
CompletedA Safety, Tolerability, Pharmacokinetics, and Immunogenicity Study of CNTO 6785 in Healthy Volunteers
Healthy
Phase 12011-02-01
CompletedPaliperidone Palmitate Flexible Dosing in Schizophrenia
Schizophrenia
Phase 32010-11-01
CompletedObservational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disea
Gastroesophageal Reflux Disease, Gastro-oesophageal Reflux, Gastro-Esophageal Reflux
2010-06-01
CompletedPrevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
Schizophrenia
Phase 32010-02-01
CompletedA Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Respon
Psoriasis
Phase 42009-10-01
CompletedVelcade Consolidation Bone Study
Multiple Myeloma
Phase 22009-09-01
CompletedA Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleo
HIV Infection, HIV, Acquired Immunodeficiency Syndrome
Phase 22009-06-01
CompletedInORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychot
Schizophrenia
2009-06-01
CompletedObservational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antip
Schizophrenia
2008-06-01
CompletedTreatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomid
Multiple Myeloma
Phase 22008-05-01
CompletedA Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attentio
Attention Deficit/ Hyperactivity Disorder
Phase 32008-02-01
CompletedA 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophre
Schizophrenia
Phase 32007-10-01
CompletedPlacebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain
Pain, Osteoarthritis, Hip, Osteoarthritis, Knee
Phase 32007-10-01
CompletedAn Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia
Schizophrenia
Phase 32007-07-01
CompletedTreatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With
HIV Infections, AIDS Virus, Human Immunodeficiency Virus
Phase 32007-06-01
CompletedAn Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participant
Schizophrenia
Phase 32007-04-25
TerminatedVelcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Tr
Multiple Myeloma
Phase 22006-12-01
CompletedAn Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma
Multiple Myeloma
Phase 22006-06-01
CompletedOpen Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS
Attention Deficit Disorder With Hyperactivity
Phase 32006-01-01
CompletedA Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Table
Schizophrenia, Psychotic Disorders
Phase 32004-10-01
CompletedA Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously
Pain, Analgesia, Patient-Controlled, Pain, Postoperative
Phase 42004-06-01
CompletedExpanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Le
Multiple Myeloma
2004-01-01
No Longer AvailableEarly Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Hepatitis C